Olanzapine treatment during pregnancy and breastfeeding: A chance for women with psychotic illness?

Psychopharmacology

Volumn 231, Issue 15, 2014, Pages 3067-3069

  Stiegler, A ^a   Schaletzky, R ^a   Walter, G ^a   Wust R ^a   Abele, H ^b   Goelz, R ^a   Farger, G ^a   Wiatr, G ^a   Fallgatter, A J ^a   Batra, A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LORAZEPAM; OLANZAPINE; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADULT; ARTIFICIAL MILK; BREAST FEEDING; BREAST MILK; CASE REPORT; DELUSION; DISORIENTATION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; EUPHORIA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LETTER; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NEWBORN; PARANOID SCHIZOPHRENIA; PATIENT MONITORING; PREGNANCY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PUERPERAL PSYCHOSIS; REMISSION; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; STEADY STATE; THOUGHT DISORDER; UMBILICAL CORD BLOOD; BLOOD ANALYSIS; CHEMISTRY; INFANT; PSYCHOTIC DISORDERS; SCHIZOPHRENIA, PARANOID; UMBILICAL VEIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD CHEMICAL ANALYSIS; BREAST FEEDING; FEMALE; HUMANS; INFANT; MILK, HUMAN; PREGNANCY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA, PARANOID; UMBILICAL VEINS;

EID: 84904425923     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-014-3647-6     Document Type: Letter

References (11)

1. Aichhorn W, Yazdi K, Kralovec K, Steiner H, Whitworth S, Stuppaeck C (2008) Olanzapine plasma concentration in a newborn. J Psychopharmacol 22:923-924
2. Bezchlibnyk-Butler KZ, Jeffries JJ (eds) (2005) Clinical handbook of psychotropic drugs, 15th edn. Hogrefe and Huber Publishers, Goettingen, Germany
3. Gardiner SJ, Kristensen JH, Begg EJ et al (2003) Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breastfed infants. Am J Psychiatry 160:1428-1431 (Pubitemid 41070917)
4. Gentile S (2004) Clinical utilization of atypical antipsychotics in pregnancy and lactation. Ann Pharmacother 38:1265-1271
5. Isoherranen N, Thummel KE (2013) Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes? Drug Metab Dispos 41:256-262
6. Lutz UC, Wiatr G, Orlikowsy T, Gaertner HJ, Bartels M (2008) Olanzapine treatment during breast feeding: a case report. Drug Monit 30:399-401
7. McCauley-Elsom K, Gurvich C, Elsom SJ, Kulkarni J (2010) Antipsychotics in pregnancy. J Psychiatr Ment Health Nurs 17:97-104
8. McKenna K, Koren G, Tetelbaum M et al (2005) Pregnancy outcome of women using atypical antipsychotic drugs: prospective comparative study. J Clin Psychiatry 66:444-449 (Pubitemid 40593572)
9. Newcomer JW (2007) Metabolic considerations in the use of antipsychotic medications: a review of recent evidence. J Clin Psychiatry 1: 20-27
10. Newport DJ, Calamaras MR, DeVane CL et al (2007) Atypical antipsychotics administration during late pregnancy: placental passage and obstetrical outcomes. Am J Psychiatry 164:1214-1220 (Pubitemid 47292410)
11. Whitworth A, Stuppaeck C, Yazdi K et al (2010) Olanzapine and breastfeeding: Changes of plasma concentrations of olanzapine in a breastfed infant over a period of 5 months. J Psychopharmacol 24:121-123